Godavari Biorefineries Limited · NSE:GODAVARIB

Godavari Biorefineries — Q3 FY25 Earnings Presentation

25 slides from Godavari Biorefineries's earnings presentation, Feb 10, 2025

  1. Slide 1: Investor Presentation filing letter to stock exchanges

    Dated: February 10, 2025 The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Tower, Bandra Kurla Complex, Bandra (E), Dalal Street Mumbai – 400 051 Mumbai-400001 Script Symbol: GODAVARIB S

  2. Slide 2: Godavari Biorefineries Limited Investor Presentation February 2025

    Godavari Biorefineries Limited Investor Presentation| February, 2025

  3. Slide 3: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Godavari Biorefineries Limited (the “Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for an

  4. Slide 4: Q3 & 9M FY25 Quarterly Performance

    Q3 & 9M FY25 Quarterly Performance

  5. Slide 5: Strategic Developments

    Strategic Developments Driving Growth and Operational Resilience Debt Reduction Using IPO Proceeds o ₹240 Crore Term Debt Repaid Using IPO Proceeds, Strengthening the Balance Sheet 01 (Enhancing Financial Strength Through o Reduction in Repayment/Interest Costs will Enhance Free Cash Flows in Upcomi

  6. Slide 6: Q3 FY25 Performance Highlights

    Q3 FY25 Performance Highlights Revenue from Operations Key Highlights Rs. 447.3 Cr ▪ Successfully reduced debt by Rs. 240 crore, enhancing free cash flow to support future investments ▪ Successfully undertaken debottlenecking 1,3-Butylene Glycol production capacity from 120 MT/month to 200 MT/month

  7. Slide 7: 9M FY25 Performance Highlights

    9M FY25 Performance Highlights Revenue from Operations EBITDA Profit Before Tax Profit After Tax (PBT) (PAT) Rs. 1,290.7 Cr Rs. (1.4) Cr Rs. (97.3) Cr Rs. (95.3) Cr Sales Volume 9M FY25 Revenue-Mix * 9M FY25 Geographical Split (in Qtl) (in MT) (in KL) +91% +19% -13% 10% 12,74,600 39,198 57,214 27% 4

  8. Slide 8: Consolidated Profit & Loss Statement – Q3 & 9M FY25

    Consolidated Profit & Loss Statement – Q3 & 9M FY25 Particulars (in INR Cr) Q3 FY25 Q3 FY24 Y-o-Y Q2 FY25 Q-o-Q 9M FY25 9M FY24 Y-o-Y Revenue from Operations 447.3 398.0 321.0 1,290.7 1,071.5 Other Income 3.6 2.0 1.1 7.4 3.9 Total Revenue 450.8 400.1 12.7% 322.1 40.0% 1,298.2 1,075.3 20.7% Cost of M

  9. Slide 9: Quarterly Financial Build-up (Seasonal Nature of Business)

    Quarterly Financial Build-up (Seasonal Nature of Business) (in INR Cr) Revenue from Operations EBITDA PBT 684 2,015 More than 100% of annual EBITDA 154 in H2 for last 3 148 financial years 1,702 1,687 141 740 652 413 618 615 1,291 138 124 384 102 757 342 447 368 398 456 332 321 48 24 47 12 287 239 4

  10. Slide 10: Company Overview

    Godavari Biorefineries Ltd \ Company Overview GROUP

  11. Slide 11: Business at a Glance

    Business at a Glance Integrated Bio-refinery across value chain: Sugar, Branded Sugar, Ethanol, Bio Based Chemicals & Power Large network of farmers Widest portfolio of Relationships built with Bio-based products in India Farmers for over 5 decades One of the top fifteen 60+ Years of Experience suga

  12. Slide 12: With over Eight decades of experience

    with over Eight decades of experience 1939 2014 2015 2016 2019 2020 2023 2024 1939: Incorporation of Launch of Jivana Brand Investment by Mandala Commencement of Distillery capacity Distillery capacity Consent to operate from Listing on NSE & Godavari Sugar Mills Capital AG Limited in manufacturing

  13. Slide 13: Integrated Bio-refinery across value chain

    Integrated Bio-refinery across value chain: Sugar, Ethanol, Bio-Chemicals, Power & Others… BHUMILABH FARM INPUTS (BIO-FERTILAZERS) SUGARCANE WAX CELLULOSE BIOGAS PRESSMUD GRAIN DERIVATIVES SUGARCANE CELLULOSE BEVERAGE SUGAR FARM ELECTRICITY 2G ETHANOL POTASH MOLASSES JUICE BAGASSE BIOCOMPOSITE RECTI

  14. Slide 14: Focus on Improving Sugarcane Valorisation

    ….with Focus on Improving Sugarcane Valorisation Widest One of the top fifteen Large network of farmers Portfolio of bio-based products in India1 sugar complexes in India in terms of Crushing Capacity KARNATAKA MAHARASHTRA SAMEERWADI MANUFACTURING FACILITY SAKARWADI MANUFACTURING FACILITY Molasses E

  15. Slide 15: Well-developed in-house Research and Development Capabilities (1/3)

    Well-developed in-house Research and Development Capabilities (1/3) R&D facilities focused on the development of new products… GBL has 3 DSIR registered R&D facilities Primarily focused on Identification and development of new potential marketable products; Navi Mumbai Improve manufacturing Sakarwad

  16. Slide 16: Well-developed in-house Research and Development Capabilities (2/3)

    Well-developed in-house Research and Development Capabilities (2/3) …supplemented through tie-ups/ MOUs MOU with KIAAR • GBL has entered into an MOU with KIAAR to carry out joint research activities in various fields including: Soil Testing Tissue culture settlings Bio Modern fertilizers Technology

  17. Slide 17: Well-developed in-house Research and Development Capabilities (3/3)

    Well-developed in-house Research and Development Capabilities (3/3) Cancer Molecule Research GBL has entered into an MOU with Dr. Sendurai Mani in connection with the research & development of small molecule inhibitors for cancer and obtained approval from the Central Drugs Standard Control Organisa

  18. Slide 18: Diversified Presence across Geographies

    Diversified Presence across Geographies GBL supplies its products to customers over 20 countries Netherlands UK Canada Switzerland France Germany Italy South Korea USA Lebanon Israel Japan India China UAE Uganda Singapore Kenya Indonesia Brazil Australia GBL has an in-house team of 37 employees dedi

  19. Slide 19: Diversified Industrial Applications

    Diversified Industrial Applications FMCG PHARMACEUTICALS FRAGRANCE BIOFUELS AGROCHEMICALS POWER CHEMICALS PERSONAL CARE AND COSMETICS 18

  20. Slide 20: Strongly positioned to Future Growth

    Strongly positioned to Future Growth Strengthen its relationships with Farmers Use renewable energy resources by accessing its biomass pool Use in-house knowledge and R&D expertise to expand its presence in bio-based chemicals Ride the global industrial and environmental green energy transition, dec

  21. Slide 21: Board of Directors

    Board of Directors Promoter has played a significant role in the development and growth of the company... Shri Samir Shantilal Somaiya (Chairman & Managing Director) • Conferred with the ‘ Knight of the Order of the Star of Italy’ • Conferred with ‘Lala Shriram National Award for Leadership in the C

  22. Slide 22: Key Awards, Accreditations and Recognitions

    Key Awards, Accreditations and Recognitions 2024 2023 2022 Godavari Biorefineries Ltd, Godavari Biorefineries Celebrating Excellence in GBL gets FICCI Chemical GBL Sameerwadi Clinches Godavari Biorefineries Godavari Biorefineries Sameerwadi awarded the Limited Wins at 4th India Quality Standards: an

  23. Slide 23: Key Growth Drivers

    Key Growth Drivers Global India Climate Change Climate Change Customer preferences Energy Security Regulation and Boardroom Commitments Transition to bio-based chemicals and green energy Farmer Income Security 22

  24. Slide 24: Key Takeaways

    Key Takeaways Diversified product portfolio Part of the Somaiya group and and well-established Integrated biorefinery with experienced promoter, board relationships with a focus on improving Sugarcane of directors, key managerial diversified marquee customer Valorisation personnel and senior base ac

  25. Slide 25: Thank You

    Thank You Godavari Biorefineries Ltd CIN: L67120MH1956PLC009707 Name – Mr. Ashish Sinha Title – AGM- IR & Finance investorrelations@somaiya.com Email – investorrelations@somaiya.com Ms. Prachi Ambre Mr. Irfan Raeen +91 83559 85370 Prachi.ambre@linkintime.co.in +91 97737 78669 Prachi.ambre@linkintime

Godavari Biorefineries — Q3 FY25 Earnings Presentation on 6ix